/Cencora%20Inc_%20HQ-by%20JHVEPhoto%20via%20iStock.jpg)
Cencora has underperformed the broader market over the past year, and Wall Street analysts appear moderately bullish about the stock’s future.
Election Day has approached, and the polls indicate a tight race between Democratic Party candidate Kamala Harris and Republican nominee Donald Trump. Neither candidate holds a meaningful edge in enough...
Johnson & Johnson JNJ infused positive optimism for the broader healthcare sector after posting solid third-quarter 2024 earnings on Oct. 15. The world's biggest healthcare products maker continued with...
For Immediate ReleaseChicago, IL – October 17, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...
In recent years, the pharmaceutical industry has witnessed a remarkable surge in the development of weight loss medications, particularly GLP-1 receptor agonists such as Ozempic and Wegovy. The global...
Cencora has outperformed the broader market over the past year, and Wall Street analysts remain bullish about the stock's prospects.
/Abbvie%20Inc%20logo%20and%20meds-%20by%20Ascannio%20via%20Shutterstock.jpg)
Despite AbbVie stock’s robust price performance compared to the broader market over the past year, Wall Street analysts are moderately bullish about the stock’s prospects.
Although Abbvie stock has been lagging behind the broader market over the past year, Wall Street analysts are still moderately bullish about its outlook.
As the great Warren Buffet was once quoted as saying "Be fearful when others are greedy, and greedy when others are fearful". With all the chaos surrounding the recent Bud Light marketing debacle, there...
VanEck announced today its distributions per share for its VanEck Vectors ® exchange-traded funds.